What other tests should be run if elliptocytes, anisocytosis, polychromasia, and hypochromasia are present?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 9, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Diagnostic Workup for Elliptocytosis, Anisocytosis, Polychromasia, and Hypochromasia

When elliptocytosis, anisocytosis, polychromasia, and hypochromasia are present on peripheral blood smear, a complete blood count with differential, iron studies, hemolysis panel, and genetic testing should be performed to determine the underlying cause.

Initial Laboratory Evaluation

Complete Blood Count and Peripheral Smear Review

  • Confirm the presence and percentage of elliptocytes (>25% suggests hereditary elliptocytosis)
  • Evaluate for other abnormal RBC morphologies
  • Check hemoglobin/hematocrit levels to assess severity of anemia
  • Assess MCV (mean corpuscular volume) to characterize the anemia
  • Review reticulocyte count to assess bone marrow response

Iron Studies

  • Serum ferritin
  • Serum iron
  • Total iron binding capacity (TIBC)
  • Transferrin saturation
  • Consider soluble transferrin receptor if iron deficiency is suspected

Hemolysis Panel

  • Lactate dehydrogenase (LDH)
  • Indirect and total bilirubin
  • Haptoglobin
  • Direct antiglobulin test (Coombs)

Second-Tier Testing

Membrane Disorder Evaluation

  • Osmotic fragility test or ektacytometry (to assess RBC membrane stability)
  • Electrophoresis of RBC membrane proteins (to identify spectrin, ankyrin, or band 4.1 abnormalities)

Genetic Testing

  • Next-generation sequencing (NGS) panel for:
    • SPTA1 (α-spectrin) - most common cause of hereditary elliptocytosis 1, 2
    • SPTB (β-spectrin)
    • EPB41 (protein 4.1)
    • PIEZO1 (recently implicated in some cases) 2

Hemoglobinopathy Evaluation

  • Hemoglobin electrophoresis
  • High-performance liquid chromatography (HPLC)
  • Consider testing for thalassemias if microcytosis is present

Specialized Testing Based on Clinical Suspicion

If Myeloproliferative Disorder is Suspected

  • Bone marrow aspirate and biopsy
  • Cytogenetic testing
  • FISH and/or RT-PCR for specific gene rearrangements 3
  • JAK2, CALR, and MPL mutation analysis

If Hemolytic Anemia is Suspected

  • G6PD activity
  • Pyruvate kinase assay
  • Other RBC enzyme assays as indicated

Diagnostic Algorithm

  1. Microcytic (low MCV) pattern with hypochromasia:

    • Complete iron studies to rule out iron deficiency anemia 4
    • Hemoglobin electrophoresis to rule out thalassemia
  2. Normocytic pattern with polychromasia:

    • Hemolysis panel to assess for hemolytic anemia
    • Reticulocyte count to assess bone marrow response
    • Consider hereditary elliptocytosis genetic testing
  3. Combined findings with family history:

    • Genetic testing for hereditary elliptocytosis/pyropoikilocytosis
    • Membrane protein analysis
    • Ektacytometry if available

Clinical Pearls and Pitfalls

  • Important: The presence of elliptocytes with polychromasia strongly suggests hereditary elliptocytosis with compensatory reticulocytosis due to hemolysis 1
  • Elliptocytosis can be a secondary finding in other conditions like iron deficiency, myelodysplastic syndrome, or myelofibrosis
  • Anisocytosis (variation in RBC size) is a nonspecific finding that requires correlation with MCV and other parameters
  • Polychromasia indicates increased reticulocytes and suggests either blood loss or hemolysis
  • Hypochromasia typically indicates decreased hemoglobin synthesis, most commonly due to iron deficiency or thalassemia

The combination of these findings warrants a systematic approach to distinguish between hereditary RBC membrane disorders, acquired causes of RBC shape abnormalities, and other hematologic conditions that may require different management strategies 5.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.